Literature DB >> 32380211

Efficient production of HPV16 E2 protein from HPV16 late mRNAs spliced from SD880 to SA2709.

Yunji Zheng1, Xiaoxu Cui1, Kersti Nilsson1, Haoran Yu1, Lijing Gong2, Chengjun Wu3, Stefan Schwartz4.   

Abstract

Human papillomaviruses (HPVs) produce a large number of alternatively spliced mRNAs, including a number of differently spliced mRNAs with the potential to produce E2 protein. To identify the alternatively spliced HPV16 mRNA with the highest ability to produce E2 protein, we have generated E2 cDNA expression plasmids representing the most common, alternatively spliced E2 mRNAs, and assessed their translational potential. Our results revealed that an mRNA initiated at the HPV16 late promoter p670 and spliced from the HPV16 5'-splice site SD880 to the HPV16 3'-splice site SA2709, located immediately upstream of the E2 ATG, produced higher levels of E2 than any of the other alternatively spliced, E2-encoding mRNAs. Utilization of a known, alternative 3'-splice site located upstream of the E2 ATG named SA2582, generated mRNAs with lower ability to produce E2 than mRNAs spliced to SA2709. Finally, analysis of HPV16 mRNA splicing demonstrated that SA2709 was more efficiently spliced to the upstream 5'-splice site SD880 than to the upstream 5'-splice site SD226. In conclusion, the HPV16 mRNA with the greatest ability to produce E2 protein is generated from the HPV16 late promoter and is spliced between HPV16 5'-splice site SD880 and HPV16 3'-splice site SA2709.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  E2; HPV16; Splicing; Translation

Year:  2020        PMID: 32380211     DOI: 10.1016/j.virusres.2020.198004

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  2 in total

1.  hnRNP G/RBMX enhances HPV16 E2 mRNA splicing through a novel splicing enhancer and inhibits production of spliced E7 oncogene mRNAs.

Authors:  Chengyu Hao; Yunji Zheng; Johanna Jönsson; Xiaoxu Cui; Haoran Yu; Chengjun Wu; Naoko Kajitani; Stefan Schwartz
Journal:  Nucleic Acids Res       Date:  2022-04-22       Impact factor: 19.160

Review 2.  Role of Viral Ribonucleoproteins in Human Papillomavirus Type 16 Gene Expression.

Authors:  Naoko Kajitani; Stefan Schwartz
Journal:  Viruses       Date:  2020-09-30       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.